在无菌体液中检测微生物度的基于磁纳米粒子的方法:验证和临床应用
Bilsen Tural1,2, Erdal Ertaş3,4, Nurullah Uzuner5
1Department of Nanotechnology, Institute of Science, Dicle University, 21280, Diyarbakir, Turkey. btural@dicle.edu.tr.
World journal of microbiology & biotechnology
|July 1, 2025
概括
一种新的纳米粒子方法显著改善了脑脊液 (CSF) 中的微生物检测,提高了诊断准确度. 这种低成本,无设备的方法提供了优越的病原体回收,特别是在低生物质样本中,优于传统离心法.
科学领域:
- 微生物学 微生物学
- 纳米技术纳米技术
- 临床诊断 临床诊断 临床诊断
背景情况:
- 在脑脊液 (CSF) 中精确检测微生物对于及时诊断和治疗感染至关重要.
- 传统的方法,如离心法,通常会产生微生物恢复率较低和假阴性,损害诊断灵敏度.
- 需要有效,可访问和敏感的方法来检测在无菌体液中的微生物度.
研究的目的:
- 评估一种基于纳米粒子的方法,以提高CSF样本中的微生物度.
- 优化纳米粒子方法的参数,包括相互作用时间和剂量.
- 与传统技术相比,评估纳米粒子方法的临床性能和诊断实用性.
主要方法:
- 优化纳米粒子相互作用时间 (1 分钟) 和剂量 (0.01 g/mL) 使用标准微生物菌株 (例如,金黄色葡萄球菌,大肠杆菌,白菌).
- 临床验证使用800个脊髓样本,由MALDI-TOF MS.证实微生物鉴定.
- 对微生物恢复率和检测极限与离心法进行比较分析.
主要成果:
- 纳米粒子方法显著改善了微生物的恢复,其度从10-2到10-9CFU/mL,检测极限低至2CFU/mL.
- 临床验证显示100%的灵敏度和特异性,确定了15个额外的真实阳性病例,这些病例被离心法遗漏.
- 该方法在低生物质样本中表现出卓越的性能,可靠地检测到10-9 CFU/mL的微生物,与离心法不同,离心法在10-7 CFU/mL以下失败.
结论:
- 基于纳米粒子的微生物度为CSF检测病原体提供了高度敏感和特定的方法.
- 这种技术大大减少了假阴性,加快了诊断,改善了患者的治疗结果.
- 它的低成本,无设备性质和可扩展性使其成为资源有限的环境的理想替代品,提高了全球准确诊断的准入.
更多相关视频
09:04Foodborne Pathogen Screening Using Magneto-fluorescent Nanosensor: Rapid Detection of E. Coli O157:H7
Published on: September 17, 2017
7.8K
09:58Computer Numerical Control Micromilling of a Microfluidic Acrylic Device with a Staggered Restriction for Magnetic Nanoparticle-Based Immunoassays
Published on: June 23, 2022
2.2K
相关概念视频
Methods to Assess Microbial Populations
Assessing microbial populations is crucial for understanding microbial roles in health, ecology, and industry. Various complementary techniques—both culture-based and molecular—enable detailed analysis of microbial abundance, diversity, and function.Viable Plate CountThe viable plate count is a traditional culture-based method used to estimate the number of living microbes in a sample. After serial dilution, the sample is spread onto nutrient agar plates. Each viable cell forms a visible...
Microbial Biosensors
Microbial biosensors are analytical devices that utilize living microbes to detect specific substances through measurable signals. These devices consist of two main components: biosensing organisms and signal-transducing elements. Biosensing organisms, such as Escherichia coli or Saccharomyces cerevisiae, are typically housed in multiwell plates connected to transducers, enabling rapid, real-time detection of target analytes.Signal Generation MechanismWhen a target analyte—such as...
Rapid Identification of Pathogens
MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...
Automated Microbial Diagnostics
Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
